These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program. Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F. Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891 [Abstract] [Full Text] [Related]
3. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Nieh S, Chen SF, Chu TY, Lai HC, Lin YS, Fu E, Gau CH. Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434 [Abstract] [Full Text] [Related]
6. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B. Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838 [Abstract] [Full Text] [Related]
8. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Carozzi F, Cecchini S, Confortini M, Becattini V, Cariaggi MP, Pontenani G, Sani C, Ciatto S. Cancer; 2006 Apr 25; 108(2):119-23. PubMed ID: 16411180 [Abstract] [Full Text] [Related]
9. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, Koliopoulos G, Malamou-Mitsi V, Karakitsos P, Paraskevaidis E. Gynecol Oncol; 2011 Apr 25; 121(1):49-53. PubMed ID: 21194734 [Abstract] [Full Text] [Related]
14. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues. Xing Y, Wang C, Wu J. Medicine (Baltimore); 2017 Jun 25; 96(26):e7302. PubMed ID: 28658133 [Abstract] [Full Text] [Related]
15. P16 immunostaining and HPV testing in histological specimens from the uterine cervix. Capobianco G, Marras V, Wenger JM, Santeufemia DA, Ambrosini G, Lutzoni R, Dessole M, Cherchi PL. Eur J Gynaecol Oncol; 2013 Jun 25; 34(3):227-30. PubMed ID: 23967551 [Abstract] [Full Text] [Related]
16. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia. Mills AM, Dirks DC, Poulter MD, Mills SE, Stoler MH. Am J Surg Pathol; 2017 May 25; 41(5):607-615. PubMed ID: 28403015 [Abstract] [Full Text] [Related]
18. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Masumoto N, Fujii T, Ishikawa M, Saito M, Iwata T, Fukuchi T, Susumu N, Mukai M, Kubushiro K, Tsukazaki K, Nozawa S. Hum Pathol; 2003 Aug 25; 34(8):778-83. PubMed ID: 14506638 [Abstract] [Full Text] [Related]
19. Significance of p53-Binding Protein 1 Nuclear Foci in Cervical Squamous Intraepithelial Lesions: Association With High-Risk Human Papillomavirus Infection and P16INK4a Expression. Kawashita S, Matsuda K, Kondo H, Kitajima Y, Hasegawa Y, Shimada T, Kitajima M, Miura K, Nakashima M, Masuzaki H. Cancer Control; 2020 Aug 25; 27(1):1073274819901170. PubMed ID: 32077330 [Abstract] [Full Text] [Related]
20. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome. Liu Y, Alqatari M, Sultan K, Ye F, Gao D, Sigel K, Zhang D, Kalir T. Hum Pathol; 2017 Aug 25; 66():144-151. PubMed ID: 28705710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]